Printable Program



April 11-13, 2019

Fort Lauderdale, FL


Saturday, April 1, 2023


9:30 - 11:45 AMSalon 8
What's New Since Our Last Conference

Chair(s): Andrea Van Beek
9:30
Welcome & Thank You For Joining Us!
Allison Burnett

9:53
Anticoagulation Stewardship
Allison Burnett
University of NM

10:14
Top Papers You Need To Know
Scott Kaatz, Tracy Minichiello

10:14
Top Papers You Need To Know
Tracy Minichiello
UCSF

10:57
New Agents, New Indications
Mark Crowther
McMaster University

11:22
Q&A Panel

11:42
Pre-Case (Special Situations)

12:00 - 1:00 PMSalon 1-4
Expert Perspectives on the Treatment of DVT/PE and Reduction in the Risk of Recurrent DVT/PE, With a Focus on DVT/PE Patients With Obesity and/or Cancer (Sponsored by Janssen Pharmaceuticals, Inc)

Distinguished faculty will provide expert perspectives on the treatment of DVT/PE and reduction in the risk of recurrent DVT/PE in patients at continued risk for recurrent DVT and/or PE. In addition, they will discuss the treatment of and reduction in the risk of recurrent DVT/PE in patients with obesity and/or cancer.

Faculty: Parth Rali, MD, Jerrica Waggoner, PharmD, BCPS, BCCP, James Williams, MS, DO, FACEP


1:15 - 3:25 PMSalon 8
Special Situations

Chair(s): Anita Rajasekhar
1:15
Warfarin Management
Candace Bryant
VA Sierra Nevada Healthcare System

1:38
Cancer And Vte
Marc Carrier
Ottawa Hospital Research Institute

2:02
Women'S Health
Sara Vazquez
University of Utah Health

2:27
Clinic Administration
Andrea Van Beek
Visalia Medical Clinic

2:54
Q&A

2:54
Post-Case

3:20
Pre-Case (The Vasculopathic Patient)

3:25 - 3:45 PMSalon 7
Break

3:45 - 5:30 PMSalon 8
The Vasculopathic Patient

Chair(s): Geoffrey Barnes
3:45
Treatment Strategies For Pad
Rachel Bond
Dignity Health Medical Group

4:25
Speciality Perspective: Neurologist
S. Andrew Josephson
UCSF

4:58
Speciality Pespective: Vascular Surgeon
Warren Gasper
University of California San Francisco / San Francisco VA

5:27
Post-Case

5:27
Q&A

5:27
Pre-Case (Starting & Stopping Anticoagulation)

5:30 - 6:30 PMSalon 7
Poster Session/Welcome Reception & 10th Anniversary of Centers of Excellence

P10
Impact Of Pharmacist Led Anticoagulation Clinic In Cardiac Specialized Hospital
Reema Syed, Jibran Bin Yousuf
National Institute of Cardiovascular Diseases, Karachi, Pakistan

P20
Maximizing The Clinical Pharmacy Technician Role Within A Centralized Anticoagulation Services Hub At The Veterans Health Administration
Sandra C Hedin, Melissa Fontana, Briana Ballister
VA Great Lakes Health Care System, Westchester, IL, United States

P30
Assessment Of Pharmacists&Rsquo; Intervention In The Initiation Of A Direct Oral Anticoagulant (Doac) Dashboard: Initial Phase
Nghi Ha, Elizabeth Renner, Denise Sutter-Long, Erin Mouland, Geoff Barnes, Michael Lanham
Michigan Medicine, Ann Arbor, MI, United States

P40
Multidisciplinary Approach In The Initiation Of A Direct Oral Anticoagulant (Doac) Dashboard
Erin Mouland, Nghi Ha, Denise Sutter-Long, Elizabeth Renner, Jackie Parsons
Michigan Medicine, Ann Arbor, MI, United States

P50
Warfarin-Rifampin Drug-Drug-Gene Interaction (Warif-G)
Muhammad Salem1, Ahmed El-Bardissy1, Mohamed Nabil Elshafei1, Ahmed Khalil1, Hesham Mahmoud1, Amr Mohamed Fahmi1,2, Mohamed Kasem1, Loulia Bader2, Mohamed Sherbash1,2, Mostafa Ibrahim Elawady1, Hazem Elewa2,3
1Clinical Pharmacy Department, Hamad Medical Corporation, Doha, Qatar, 2College of Pharmacy, QU Health, Qatar University , Doha, Qatar, 3Biomedical and Pharmaceutical Research Unit, Doha, Qatar

P60
Protocolized Critical Inr Management In A Pharmacist-Led Anticoagulation Clinic
Christi A Albert1, Ethan Meyer1,2, Anne Rose1
1UW Health , Madison, WI, United States, 2University of Wisconsin-Madison School of Pharmacy, Madison, WI, United States

P70
Barriers And Facilitators To Warfarin Patient Self-Management In The Us Healthcare System
Aaron Wilson1, Aubrey Jones1, Stacey Slager2, Sara Vazquez1,3, Ryan Fleming3, Geoffrey Barnes4, Katelyn Sylvester5, Linh Chan6, Bishoy Ragheb7, Jacob Kean8, Daniel Witt1
1University of Utah College of Pharmacy, Salt Lake City, UT, United States, 2University of Utah Office of Research Integrity and Compliance, Salt Lake City, UT, United States, 3University of Utah Health, Salt Lake City, UT, United States, 4University of Michigan, Ann Arbor, MI, United States, 5Brigham and Women�s Hospital, Boston, MA, United States, 6VA Loma Linda Healthcare System, Loma Linda, CA, United States, 7VA Eastern Colorado Health Care System, Aurora, CO, United States, 8University of Utah School of Medicine, Salt Lake City, UT, United States

P80
EValuating The Process Of TRansitionIng Atrial Fibrillation (Af) Patients From WArfarin To A Direct ORal ANticoagulant (Doac) IN A�PHarmacist-Led ANticoagulation CLinic�
Mursal Noor, Chris Amadi, Mark Canevari, Kassandra Bugg
UC Davis Health, Sacramento, CA, United States

P90
Anticoagulant Management Of Covid-19 Patients With Thrombotic Complications�
Anish Joshi1, Arushi Garud1, Neha Thomas1, Atul Laddu1, Jawed Fareed2
1Global Thrombosis Forum, Suwanee, GA, United States, 2Loyola University , Chicago, IL, United States

P100
Clinical And Genetic-Based Refinement Of The Warfarin Dose
Noor Al-Hammadi1,2, Kevin B. Stephenson1, Jie Hou3, Charles S. Eby1,5, Anne R. Bass4, Brian F. Gage1
1Department of Medicine, Washington University in St. Louis, Saint Louis, MO, United States, 2Department of Health and Clinical Outcomes Research, Saint Louis University, Saint Louis, MO, United States, 3Department of Computer Science, Saint Louis University, Saint Louis, MO, United States, 4Department of Medicine, Hospital for Special Surgery/Weill Cornell Medicine, New York, New York, NY, United States, 5Department of Pathology and Immunology, Washington University in St. Louis, Saint Louis, MO, United States

P110
Biomarkers Of Hemostatic Dysregulation
Shivam Gupta1, Divya Honavar1, Neha Thomas1, Atul Laddu1, Jawed Fareed2
1Global Thrombosis Forum, Suwanee, GA, United States, 2Loyola University, Chicago, IL, United States

P120
Utilization Of A Direct Oral Anticoagulant Population Management Tool: Standardizing Assessment Of Hemoglobin Flags
Heather Poepping1, Julie Spenner1, Michelle Anderson1, Christina Bookwalter1, Arthur Allen2
1Minneapolis VA Health Care System, Minneapolis, MN, United States, 2VA Salt Lake City Health Care System, Salt Lake City, UT, United States

P130
Warfarin Use Is Associated With Higher Rates Of Clinically Relevant Epistaxis Compared To Direct Oral Anticoagulants
Khristian S. Burke1, Xiaowen Kong2, Brian Haymart2, Debbie DeCamillo2, Mona Ali3, Geoff D. Barnes2, Scott Kaatz4
1Central Michigan University College of Medicine, Mount Pleasant, MI, United States, 2Michigan Medicine, Ann arbor, MI, United States, 3Beaumont Health System, Royal Oak, MI, United States, 4Division of Hospital Medicine, Henry Ford Hospital, Detroit, MI, United States

P140
Prevalence And Predictors Of Underdosing In Patients Initiating Direct Oral Anticoagulants For Atrial Fibrillation Or Venous Thromboembolism
Chloe Kazaglis1, Xiaowen Kong1, Brian Haymart1, Xiaokui Gu1, Deborah DeCamillo1, Mona Ali2, Scott Kaatz3, Geoffrey D Barnes1
1Frankel Cardiovascular Center-University of Michigan Medicine Health, Ann Arbor, MI, United States, 2William Beaumont Hospital, Royal Oak, MI, United States, 3Henry Ford Hospital-Division of Hospital Medicine, Detroit, MI, United States

P150
Characterization Of Direct-Acting Oral Anticoagulants (Doac) Dosing: �A Cross-Sectional Real-World Evaluation Of Us Patients With Non-Valvular Atrial Fibrillation
Mohammad B. Ateya, Timothy J Hartman, Jon Glover, Laura L Manzey, Lynette T Davis, Anna Gleboff, Bonnie DeLor
Pfizer Inc., New York, NY, United States

P160
Procedural/Surgical Rhythm Control For Patients With Atrial Fibrillation: A Meta-Analysis
Bryce Montane, Shiyang Zhang, Jonathan Wolfe, Sabrina Prime, Daniel Cooper, Michelle Doering, Brian Gage
Washington University School of Medicine, St. Louis, MO, United States

P170
Eligibility And Discussions Of Left Atrial Appendage Occlusion In Patients On Anticoagulation For Atrial Fibrillation
Amber Co, Brian Haymart, Deborah DeCamillo, Geoffrey D Barnes
University of Michigan Health, Frankel Cardiovasclar Center, Ann Arbor, MI, United States

P180
Thrombogenicity Of An Implantable Cardioverter Defibrillator Lead Beats Anticoagulation: A Case Report
Abdelsalam/S Elshaikh, Mohammed/A Wazzan, Ghassan/H Elkadi, Judith/A Mackall, Kelsey/E Gray, Dillon Gibson
University Hospitals of Cleveland Medical Center, Cleveland, OH, United States

P190
Sars-Cov-2 Infection And The Management Of Long-Term Warfarin Therapy
Lisa J. Mahoney1, Joseph R. Flynn2, Jan A. Anderson3, Kristin C. Mara3, Annette Faller1, Harold J. Hellweg4
1Mayo Clinic Health System, La Crosse, WI, United States, 2Mayo Clinic Health System, Mankato, MN, United States, 3Mayo Clinic , Rochester, MN, United States, 4Mayo Clinic Health System, Owatonna , MN, United States

P200
A Population Health Approach To Stroke Prevention In Atrial Fibrillation/Flutter: Targeting The Untreated While Prioritizing Health Disparities
Jeffery Kibert1, Arthur Allen1, T. Scott Wall1, Linda Chia2, Patrick Spoutz3
1VA Salt Lake City Health Care System, Salt Lake City, UT, United States, 2Veterans Integrated Service Network 8, St. Petersburg, FL, United States, 3Veterans Integrated Service Network 20, Vancouver, WA, United States

P210
Community-Based�Antithrombotic Stewardship To Combat Health Disparities In Peripheral Artery Disease
Kristie Roberts, Kelly Rudd
Oklahoma State University Center of Health Sciences, Tulsa, OK, United States

P220
Scoping Review: Racial Disparities In Anticoagulation Care Delivery (Interim Data)
Sara R. Vazquez1, Naomi Y. Yates2, Craig Beavers3, Darren Triller4, Mary McFarland5
1University of Utah Health , 2Kaiser Permanente , 3University of Kentucky College of Pharmacy, 4Anticoagulation Forum , 5University of Utah Eccles Health Sciences Library

P230
A Comparison Of Antifactor Xa (Afxa) Nomograms And Activated Partial Thrombin Time (Aptt) Nomograms For Nurse Driven Systemic Unfractionated Heparin (Ufh) Infusions
Kaitlyn Loi
Community Medical Centers, Fresno, CA, United States

P240
Improving The Diagnosis And Management Of Heparin Induced Thrombocytopenia (Hit) With Electronic Consultation
Jori May1, K. Ria Hearld2, Michael Denaburg3, Gretchen Kennamer4, Laura Taylor5, Marisa Marques6
1Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States, 2Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, United States, 3Department of Pharmacy, University of Alabama at Birmingham, Birmingham, AL, United States, 4Clinical Informatics, University of Alabama at Birmingham, Birmingham, AL, United States, 5Special Coagulation Service, University of Alabama at Birmingham, Birmingham, AL, United States, 6Division of Laboratory Medicine, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States

P250
Potential Drug-Drug Interactions With Anticoagulants Among Post-Operated Patients Of A Tertiary Cardiac Care Institute In Pakistan
Ahmad Ullah Humza1, Abdul Hameed2, Sadia Ghousia Baig3, Afshan Siddiq3, Attaullah Khan1, Saima Salim1, Jibran bin Yousuf1
1National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan, 2Sindh Institute of Management & Technology (SMIT), Karachi, Pakistan, 3Department of Pharmacology, University of Karachi, Karachi, Pakistan

P260
Assessing The Implication Of Increased Bleeding Risk Associated With Concurrent Use Of Rivaroxaban And Dual P-Gp Inhibitor And Moderate Cyp3A4 Inhibitors.
Kisha A Dunkley1, Elise Lee2, Laura Calderon Lugo2, Ashwini Niranjan-Azadi1
1The Johns Hopkins Hospital, Baltimore, MD, United States, 2Notre Dame of Maryland University, Baltimore, MD, United States

P270
Identification Of Incorrect Dosing Of Direct Oral Anticoagulants By Ward Pharmacists: A Multidisciplinary Approach To Improve Patient Safety �
Fiona Nagele, Emilie Tudela-Lopez, Michelle Hana, Martin Holbik, Simone Zotter, Maria Amtmann, Klara Jadrna, Petra P�lzleitner, Ilse Pointner, Barbara Datterl, Maria Bachmann, Sonja Steininger-Salmer, Florian Pichler, Gerda Laml-Wallner, Gunar Stemer, Martina Anditsch
Pharmacy Department of the University Hospital Vienna, Vienna, Austria

P280
Leveraging Learners In The Education Of Anticoagulated Patients - The Leap Feasibility Pilot Study
Parsa Mahmoudi1, Joseph Basi1, Harriet Kusi2, Amy L. Ives2,3
1Georgetown University School of Medicine, Washington, DC, United States, 2MedStar Georgetown University Hospital, Washington, DC, United States, 3University of Maryland School of Pharmacy, Baltimore, MD, United States

P290
Homogeneous Enzyme Immunoassay For The Determination Of Rivaroxaban In Human Plasma
Soon Oh, Moonbin Yim, Khanhlinh Pham, Rajendra Singh, Robert O'Malley, Tom Houts, Byung Moon, Johnny Valdez
ARK Diagnostics, Fremont, CA, United States

P300
Inr Management In Antiphospholipid Syndrome Patient With Type Ii Secondary Arteriovenous Fistula
Jayllex N. Mills, H. Paige Erdeljac
The Ohio State University, Columbus, OH, United States

P310
Homogeneous Enzyme Immunoassay For The Determination Of Apixaban In Human Plasma
Soon Oh, Jane Scheill, Khanhlinh Pham, Rajendra Singh, Robert O'Malley, Tom Houts, Byung Moon, Johnny Valdez
ARK Diagnostics, Fremont, CA, United States

P320
A Case Of Persistently Subtherapeutic�Antifactor Xa (Afxa) Levels Despite�Heparin Infusion Dose Uptitration In A Patient With Left Ventricular Assist Device (Lvad)
Kaitlyn Loi
Community Medical Centers, Fresno, CA, United States

P330
Outcomes Of Warfarin Home Inr Monitoring Vs Office-Based Monitoring: A Retrospective Claims-Based Analysis
Andrea Van Beek1, Bishoy Ragheb2, Erika Price3, 4, Joanna MacEwan5, Mariola Moeyaert6, Jack Ansell7
1Visalia Medical Clinic, Visalia, CA, United States, 2VA Eastern Colorado Health Care System, Aurora, CO, United States, 3San Francisco VA Health Care System, San Francisco, CA, United States, 4University of California - San Francisco, Department of Medicine, San Francisco, CA, United States, 5Genesis Research, Hoboken, NJ, United States, 6University at Albany - SUNY, Albany, NY, United States, 7Hofstra Northwell Zucker School of Medicine, Hempstead, NY, United States

P340
Impact Of Electronic Transmission Of Patient Pt/Inr Home Self-Testing Results
Terea Williamson, DPT, BS1, Stuart Blackwell, BA1, Brittany Compton, BSN, RN1, Paul Sommers, BSN, RN1, Seok-Won Lee, PhD2, Sandra Gomberg, DNP3, JoAnne Resnic, MBA, BSN, RN3
1Orthodynamics Company, Inc. (ODI), Noblesville, IN, United States, 2CoaguSense, Inc., Fremont, CA, United States, 3Stel, Life, Inc. , Philadelphia, PA, United States

P350
A Comparison Of Historical Bridging Practices Within A Single Center With Recommendations Found In The 2022 Updated Enoxaparin Bridging Guidelines For Patients On Warfarin And An Evaluation Of Bleeding Rate
Khrystyna Hlukhenka1, Michael Ellerbroek1, Erin Carson1,2, Ammie Hodges1
1University of Wisconsin-Madison (UW) Northern Illinois, Rockford, IL, United States, 2University of Illinois Chicago , Chicago, IL, United States

P360
2021 Encore: Successful Adaptation Of The Management Of Anticoagulation In The Peri-Procedural Period (Mappp) Active Clinical Decision Support Into A Nurse-Driven Protocol
Kelly Rudd1, Robin Lopez2, Penny Klingman2
1Oklahoma State University Center for Health Sciences, Tulsa, OK, United States, 2Bassett Healthcare Network, Cooperstown, NY, United States

P370
Operationalizing Standardized Periprocedural Anticoagulation Management: A Stewardship Initiative
Kelly Rudd1,2, Amanda Winans2, Darren Triller3
1Oklahoma State University Center for Health Sciences, Tulsa, OK, United States, 2Bassett Healthcare Network, Cooperstown, NY, United States, 3The Anticoagulation Forum, Newton, MA, United States

P380
Perioperative Management Of Direct Oral Anticoagulants And Antiplatelet Therapy For Gastrointestinal Procedures� �
Rachel Fernandes, Tara Lech, Jana Montgomery
Lahey Hospital and Medical Center, Burlington, MA, United States

P390
What&Rsquo;S Stopping You: Impact Of Anticoagulation On Procedural Delays And Cancellations At An Academic Safety Net Hospital.�
Smitha M John1, Alyssa E Utz2, Abdusebur Jemal1, Emad Qayed3, Jason M Brown3, Mikhail Y Akbashev3
1Morehouse School of Medicine, Atlanta, GA, United States, 2Grady Memorial Hospital, Atlanta, GA, United States, 3Emory University Department of Medicine, Atlanta, GA, United States

P400
Development Of Clinical Pharmacist Led Anticoagulation Stewardship Program In Cardiac Care Setting In Developing Country.
Sumaira khan1, Dr bashir hanif1, munazza qureshi1, amna jenhangir1
1Tabba Heart Institute, KARACHI, Pakistan, 2Tabba Heart Institute, KARACHI, Pakistan, 3Tabba Heart Institute, KARACHI, Pakistan, 4Tabba Heart Institute, KARACHI, Pakistan

P410
External Validation Of Published Heparin Population Pharmacokinetic Models For Model-Informed Precision Dosing
Jasmine H. Hughes1, Andrea N. Reed2, Laura Frantz2, Gerald J. Rebo2, Jonathan D. Faldasz1, Ron J. Keizer1
1InsightRX, San Francisco, CA, United States, 2Novant Health, Charlotte, NC, United States

P420
Co-Prescribing Of Antiplatelets With Direct Oral Anticoagulants: A Medication Safety Initiative
David Parra1,2, Jeremy B. Sussman3,4, Jessica J. Lucas5, Janin Monterrey6, Litzalee Camacho-Vega6, Joseph J. Fierro7, Patricia Fernandez-Quevedo8, Maria Jose Irias8, Jaclyn Stoppi9, Robert D. Stewart10, Natalie R. Ciccone11, Marissa N. Egipciaco11, Briana S. Ballister12, Charity S. Chen4, Jacob E. Kurlander3,4, for the VISN 8 PBM Pharmacy Anticoagulation Workgroup1
1Veterans Health Administration VISN 8 Pharmacy Benefits Management, Bay Pines, FL, United States, 2University of Minnesota, College of Pharmacy, Minneapolis, MN, United States, 3University of Michigan , Ann Arbor, MI, United States, 4Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, United States, 5North Florida South Georgia Veterans Health Care System, Gainesville, DC, United States, 6Caribbean Veterans Affairs Health Care System, San Juan, PR, United States, 7Tamp Bay Veterans Affairs Health Care System, Tampa Bay, FL, United States, 8Miami Veterans Affairs Health Care System, Miami, FL, United States, 9West Palm Beach Veterans Affairs Health Care System, West Palm Beach, FL, United States, 10Bay Pines Veterans Affairs Health Care System, Bay Pines, FL, United States, 11Orlando Veterans Affairs Health Care System, Orlando, FL, United States, 12Veterans Health Administration Pharmacy Benefits Management VA MedSAFE, Washington, DC, United States

P430
Implementation Of A Comprehensive Perioperative Anticoagulation Management Program Leveraging The Electronic Health Record At An Academic Medical Center
Lisa J. Moherman, Valerie J. Brown, Kathryn Kasicky, Hannah B. Trickett
West Virginia University (WVU) Medicine, Morgantown, WV, United States

P440
Anti-Xa Target Attainment & Dose Selection: Comparison Of Pharmacokinetic Model-Guided Dosing Versus Institutional Practice
Jasmine H. Hughes1, Andrea N. H. Reed2, Laura Frantz2, Gerald J. Rebo2, Jonathan D. Faldasz1, Ron J. Keizer1
1InsightRX, San Francisco, CA, United States, 2Novant Health, Charlotte, NC, United States

P450
Evaluating The Prevalence Of Osteopenia Or Osteoporosis In Veterans On Long-Term Warfarin Therapy
Julia Lee, Candace Bryant, Cecilia Gollaher
VA Sierra Nevada Healthcare System, Reno, NV, United States

P460
Antithrombosis Stewardship Within A Veterans Affairs Health System: Review Of Combined Oral Anticoagulants And Antiplatelets�
Candace Bryant1, Spencer Davidson2, Cecilia Gollaher1, Rajendra Mishra3
1VA Sierra Nevada Health Care System, Reno, NV, United States, 2VA Durham Health Care System, Durham, NC, United States, 3Magellan Rx, Phoenix, AZ, United States

P470
Direct Oral Anticoagulants: An In-Depth Look At Harmful Events Reported To Ecri And The Ismp Patient Safety Organization
Jose Nery1,2, Matthew Grissinger1,2
1Institute for Safe Medication Practices, Plymouth Meeting, PA, United States, 2ECRI, Plymouth Meeting, PA, United States

P480
2021 Encore:�National Board Certification As An Anticoagulation Care Provider: Barriers, Motivators And New Cacp Recertification Processes
Kelly Rudd1,2, Lynn B. Oertel2,3, M. Jane Swartz4, Jennifer Palmer4
1Oklahoma State University Center for Health Sciences, Tulsa, OK, United States, 2National Certification Board of Anticoagulation Care Providers, Chicago, IL, United States, 3Massachusetts General Anticoagulation Management Service, retired, Boston, MA, United States, 44University of Southern Indiana College of Nursing and Health Professions, Evansville, IN, United States

P490
Antiplatelet De-Escalation In Patients Receiving Oral Anticoagulants:� Less Is More
Jennifer Crowley1, Litzalee Camacho-Vega2, Natalia Y. Ayala-Mu�iz3
1Clinical Pharmacy Specialist-Cardiology, Veterans Affairs Caribbean Healthcare System,, San Juan, PR, United States, 2Clinical Pharmacist Specialist-Anticoagulation, Veterans Affairs Caribbean Healthcare System, San Juan, PR, United States, 3Pharmacy PGY1 Resident 2021-2022, Veterans Affairs Caribbean Healthcare System, San Juan, PR, United States

P500
Safe Timely Resumption Of Pharmacologic Thromboembolism Prevention In Hospitalized Patients With A Recent Major Bleed
Harsh Sharma, Oksana Petrechko, David B. Jackson, Natasha Khan, Allison Burnett, Mindy Mason, Rachel Garcia, Taylor Goot, Christopher Bartlett, Jessica Zimmerberg-Helms
University of New Mexico Health Sciences Center, Albuquerque, NM, United States

P510
Aspirin Deprescribing In Patients On Oral Anticoagulation For Atrial Fibrillation Or Venous Thromboembolism: A National Survey Of Clinician Practices
Sylvia Ou1, Erin Pozzolano1, Avisek Datta2, Dulal Bhaumik2, Nancy Shapiro1
1Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, United States, 2Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL, United States

P520
The Challenges Of Patient Activation: A Pilot Factorial Trial Examining Multilevel Interventions To Reduce Bleeding Risk In Patients Prescribed Combination Antithrombotic Therapy
Jacob E. Kurlander1,2,3, Geoffrey D. Barnes1,2,4, Danielle Helminski1, Sarah L. Krein1,2,3, Caroline R. Richardson5, Kelley M. Kidwell6, Liyang Yuan6, Michael Lanham7,8,9, James B. Froehlich1,2,4, Raymond De Vries2,7,11, Linda K. Perry4, Jacqueline Parsons4, Nghi Ha4, Tina Alexandris-Souphis4, Joyce J. Kim1, Sameer D. Saini1,2,3
1Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States, 2Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, United States, 3Veterans Affairs (VA) Ann Arbor Center for Clinical Management Research, Ann Arbor, MI, United States, 4Frankel Cardiovascular Center, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States, 5Department of Family Medicine, Brown University , Providence, RI, United States, 6Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, United States, 7Department of Learning Health Sciences, University of Michigan, Ann Arbor, MI, United States, 8Department of Gynecology and Obstetrics, University of Michigan, Ann Arbor, MI, United States, 9University of Michigan Office of Clinical Informatics, Ann Arbor, MI, United States, 10Health Information Technology and Services, University of Michigan, Ann Arbor, MI, United States, 11Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, MI, United States

P530
The Nationwide Implementation Of A Population Management Dashboard For Monitoring Direct Oral Anticoagulants: Insights From The Veterans Affairs Health System
Michael P. Dorsch1, 2, 3, Charity S. Chen4, Arthur L Allen5, Anne E. Sales6, F. Jacob Seagull7, Patrick Spoutz8, Jeremy B. Sussman3,4,9, Geoffrey D. Barnes2, 3, 9
1College of Pharmacy, University of Michigan, Ann Arbor, MI, United States, 2Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI, United States, 3Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, United States, 4Ann Arbor Veterans Health Affairs, Ann Arboor, MI, United States, 5Veterans Affairs Salt Lake City Health Care System , Salt Lake City, UT, United States, 6School of Nursing, University of Missouri,, Columbia, MO, United States, 7Michigan Medicine - Center for Bioethics and Social Science in Medicine, University of Michigan, Ann Arbor, MI, United States, 8VISN 20 Network Office, Veterans Health Affairs, Vancouver, WA, United States

P540
The Utility Of An Inr And Best Practice For Monitoring Doac Therapy�
Amber N Chiplinski1, Emily A Bowman2, Tessa A Keeting1, Sarah M Pagenhardt1, Marco Caccamo1
1West Virginia University Medicine, Morgantown, WV, United States, 2West Virginia University School of Pharmacy, Morgantown, WV, United States

P550
Patient Compliance With Aspirin And Rivaroxaban Post Elective Joint Replacement Surgery: A Quality Assurance Initiative
Laurie A. Sardo1,2, Julia A. Bayadinova1
1St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada, 2McMaster University, Faculty of Nursing, Hamilton, ON, Canada

P560
Measuring The Impact Of Va Text Reminder Messages For Patients Taking Direct Oral Anticoagulants
Geri Kimura, Julia Whealin, Reese Omizo
Department of Veteran Affairs Pacific Islands Health Care System, Honolulu, HI, United States

P570
Medication Use Evaluation: Cangrelor For Percutaneous Coronary Intervention And Bridging
Jenni J. Klausen, Megan L. Robinson, Linh T. Nguyen, David D. Quach
Bryan Medical Center, Lincoln, NE, United States

P580
Cancer Associated Thrombosis: Optimizing The Prevention And Treatment In High Risk Cancer Patients
Nydia Khargie, Susan Jenkins, Erik Yeo
University Health Network, Toronto, ON, Canada

P590
Impact Of Clinical Pharmacy Services On Direct Oral Anticoagulant Medication Selection And Dosing In The Ambulatory Care Setting
Naomi Y. Yates, Stephanie A. Hale
Kaiser Permanente, Atlanta, GA, United States

P600
Continuum Of Stewardship: Oversight And Continual Process Improvement Of A Population Management Tool In Veterans Health Administration
Jeffery L Kibert II1, David Parra2.3, Briana Ballister4, Von Moore5, Francesca Cunningham5, Arthur Allen1, Patrick Spoutz6
1VA Salt Lake City Health Care System , Salt Lake City , UT, United States, 2Veterans Health Administration VISN 8 Pharmacy Benefits Management, Bay Pines, FL, United States, 3University of Minnesota, College of Pharmacy, Minneapolis , MN, United States, 4Veterans Health Administration Pharmacy Benefits Management VA MedSAFE, Washington, DC, United States, 5Veterans Affairs Center for Medication Safety/Pharmacy Benefits Management Services, Hines, IL, United States, 6Veterans Health Administration Northwest Health Network, Vancouver, WA, United States

P610
Defining Success In Anticoagulation Stewardship: The Development Of Doac Population Health Management Quality Reports In Veterans Health Administration
Jennifer Vuong1, Briana Ballister2, Angela Casperson1, Arthur Allen1
1VA Salt Lake City Health Care System, Salt Lake City, UT, United States, 2Veterans Health Administration Pharmacy Benefits Management VA MedSAFE, Washington, DC, United States, 3VA Salt Lake City Health Care System, Salt Lake City, UT, United States, 4VA Salt Lake City Health Care System, Salt Lake City, UT, United States

P620
The Effect Of A Multi-Healthcare Organization Quality Improvement Project On Aspirin Deprescribing
Noelle A Ryan1, Geoff Barnes2, Amanda Winans3, Jennifer Hardman4, Tara Lech5, Daniel Boldt6, Heather Eid7, Lauryl ristufek Hanf8, Krista Luck9, Alicia Wen10, Nancy Shapiro11, Anya Gunn12, Anne Rose13, Candace Bryant14, Kristy Shields15, Ryan Fleming16
1Henry Ford Health, Detroit, MI, United States, 2University of Michigan Medical Center, Ann Arbor, MI, United States, 3Bassett Health, Cooperstown , NY, United States, 4Froedtert Hospital, Milwaukee, WI, United States, 5Lahey Hospital and Medical Center, Burlington, MA, United States, 6Mercy Health, Grand Rapids, MI, United States, 7Mercy Health St. Anne Hospital, Toledo, OH, United States, 8Mercy Health St. Charles Hospital, Oregon , OH, United States, 9Mission Hospital, Asheville, NC, United States, 10Stanford Health Care and Clinics, Palo Alto, CA, United States, 11University of Illinois, Chicago, IL, United States, 12University of Colorado Health Heart and Vascular Clinic, Steamboat Springs, CO, United States, 13University of Wisconsin Medical Center, Madison, WI, United States, 14VA Sierra Nevada Health Care System, Reno, NV, United States, 15Waldo County General Hospital Anticoagulation Clinic, Belfast , ME, United States, 16University of Utah Health, Sandy , UT, United States

P630
Providers\' Perception Of The Impact Of Covid-19 On Warfarin Therapy Management
Mennat-Allah Abdin, John A. Saunders, Daniel M. Witt
university of Utah, Salt Lake City, UT, United States

P640
Improving The Understanding Of Population Health-Based Digital Tools For Anticoagulation Management
Aaron S. Wilson1, Darren M. Triller2, Arthur Allen3, Allison Burnett4, Julie A. Gouveia-Pisano5, Allison Brenner5, Barbara K. Pritchard5, Charles Medico5, Sara R. Vazquez1, Daniel M. Witt1, Geoffrey D. Barnes6
1University of Utah College of Pharmacy, Salt Lake City, UT, United States, 2Anticoagulation Forum, Newton, MA, United States, 3VA Salt Lake City Health Care System, Salt Lake City, UT, United States, 4University of New Mexico Health Sciences Center, Albuquerque, NM, United States, 5Pfizer Inc., New York City, NY, United States, 6Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI, United States

P650
Low Dose Prothrombin Complex Concentrate For Direct Oral Anticoagulant Reversal�
Victoria Cancelliere1, Ashley Mulvey2, Anne Rose2
1University of Wisconsin-Madison, School of Pharmacy, Madison, WI, United States, 2University of Wisconsin Health, Madison, WI, United States

P660
The Use Of Andexanet Alfa Vs. Four Factor Prothrombin Complex Concentrates In The Reversal Of Life-Threatening Intracranial Hemorrhage
Edward De Leo1, Vivian Irizarry Gatell2, Michael Bacchus1, Yang Zhang1, Carrie Lagasse1, Anna Khanna1, Neil Harris1, Marc Zumberg1
1University of Florida, Gainesville, FL, United States, 2Moffitt Cancer Center, Tampa Bay, FL, United States

P670
A Case Of Dabigatran Accumulation With Hemorrhage And Coagulopathy�
Jessica Greenberg1, Ira Kraft2, Khanh Nghiem3, Ali Elsaadi 4, Mei Li Kwong5, Shelley Kalsi6
1Hematology Consult Section, Division of Intramural Research, National Heart Lung Blood Institute, Bethesda, MD, United States, 2National Cancer Institute, Bethesda, MD, United States, 3Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD, United States, 4Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States, 5Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States, 6Hematology Consult Section, Division of Intramural Research, National Heart Lung Blood Institute, Bethesda, MD, United States

P680
Vascular Thrombosis In Antiphospholipid Syndrome Patient Despite Appropriate Anticoagulation Therapy
Yolanda McKoy-Beach1, Peter Sealy2, Sheeyra Upadhyay2
1Howard University College of Pharmacy, Washington,, DC, United States, 2Howard University Hospital, Washington,, DC, United States

P690
Using Anti-Xa Monitoring To Manage Anticoagulation For Mechanical Heart Valves During Pregnancy
Annabel K. Frank, Margaret C. Fang
University of California, San Francisco, San Francisco, CA, United States

P710
Evaluation Of Apixaban Anti-Xa Activity, Efficacy, And Safety Post-Bariatric Surgery
Katelyn M. Currier1, Toby C. Trujillo1, Jonathan A. Schoen2, Rizwan Ahmed2, Surabhi Palkimas1
1University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, United States, 2University of Colorado Hospital, Aurora, CO, United States

P720
Pharmacist-Led, Checklist Driven Care Did Not Improve Adherence In Ambulatory Patients Starting Or Resuming A Direct Oral Anticoagulant After Setback&Ndash; The Leave Safe With Doacs Study
Aaron S Wilson, Thu Pham, Daniel Mbusa, Parth Patel, Soumya Chennupati, Sybil Crawford, Alok Kapoor
UMass Chan Medical School, Worcester, MA, United States

P730
2021 Encore:�Operationalizing Efficient And Effectiveness Anticoagulation-Related Discharge Communication
Kelly Rudd1, Brenda Davies-Wait2, Chad Welch2, Anna VanDerwerken2
1Oklahoma State University Center for Health Sciences, Tulsa, OK, United States, 2Bassett Healthcare Network, Cooperstown, NY, United States

P740
Insurance Adjudication Of Anticoagulants Prior To Discharge - Results From A Pilot Study
Joseph Basi1, Parsa Mahmoudi1, Harriet Kusi2, Amy L. Ives2,3
1Georgetown University School of Medicine, Washington, DC, United States, 2MedStar Georgetown University Hospital, Washington, DC, United States, 3University of Maryland School of Pharmacy, Baltimore, MD, United States

P750
Establishment And Utilization Of An Advanced Practice Provider-Led Clinic For Newly Diagnosed Venous Thromboembolism
Cassi Frank, Raj Kasthuri, Nigel Key, Micah Mooberry, Stephan Moll
University of North Carolina, Chapel Hill, Chapel Hill, NC, United States

P760
Impact Of Cancer On Outcome Among Hospitalized Patients With Venous Thromboembolism: Data From National Inpatient Sample
Sijan Basnet1, Biraj Shrestha2, Luis H Eraso1, Taki Galanis1, Anthony Macchiavelli1, Geno Merli1
1Thomas Jefferson University Hospital , Philadelphia, PA, United States, 2Reading Hospital, West Reading, PA, United States

P770
Anticoagulation (Ac) Clinical Pharmacy Practitioners (Cpps) Utilization Of Direct Oral Anticoagulant (Doac) Starter Packs In The Ambulatory Care Setting For Outpatient Treatment Of Acute, Stable Deep Vein Thrombosis (Dvt)
Bonnie J. Whittington, Kidest-Mimi A. Demesse, April Y. Allen
VA North Texas Health Care System, Dallas, TX, United States

P780
Direct Oral Anticoagulants For The Treatment Of Splanchnic Vein Thrombosis - A Systematic Review And Meta-Analysis
Allen Li1,2, Ming Zhang3, Harry Li4, Ali Eshaghpour5, Marc Carrier2,6, Philip Wells2,6, Mark Crowther5
1The Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, Canada, 2Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada, 3Michael G. DeGroote School of Medicine, Hamilton, ON, Canada, 4Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada, 5Department of Medicine, McMaster University, Hamilton, ON, Canada, 6Department of Medicine, University of Ottawa, Ottawa, ON, Canada

P790
Thromboembolism Risk And Management Pattern In Hospitalized Covid-19 Patients: A Single-Center Experience In Ethiopia
Tamrat Assefa Tadesse, Ashenafi Teklu
Addis Ababa University, Addis Ababa, Ethiopia

P800
Attributes Of Randomized Controlled Trials And Their Associations With Funding Source In Venous Thromboembolism Prophylaxis For Patients With Cancer: A Bibliographical Analysis
Jayhan A. Kherani1, Lucy Zhao1, Pei Y. Li2, Kevin Zhang2, Angelina Horta1, Christine Lin1, Allen Li3, Ali Eshaghpour4, Mark A. Crowther4
1Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada, 2Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada, 3Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada, 4Department of Medicine, McMaster University, Hamilton, ON, Canada

P810
Inferior Vena Cava Filter Use At A Large Community Hospital: A Cross-Sectional Analysis
Samantha Bolger1, Kaity Greco1, Yuxin Bai1, Stephanie Fontyn1, Caroline Hamm1,2, Andrea Cervi1,2
1Schulich School of Medicine and Dentistry, London, ON, Canada, 2Department of Medical Oncology, Windsor Regional Cancer Centre, Windsor, ON, Canada

P820
Significance Of The Loading Phase Duration Of Apixaban On Bleeding Events In Patients Treated For Newly Diagnosed Venous Thromboembolism After Initial Parenteral Anticoagulation Treatment
Lauren Jackson, Amanda Gillion, Jacob Marler
Memphis VA Medical Center, Memphis, TN, United States

6:30 - 7:30 PMSalon 1-4
Outcomes of Patient Self-Testing for Warfarin Therapy: Key Findings from Retrospective Studies (Sponsored by Acelis Connected Health)

Session will highlight findings from two retrospective studies on patient self-testing for warfarin therapy. The first study looked at virtual versus in-person education for PST for warfarin therapy, showing that virtual education is effective and should continue to be an option. The second study was a retrospective claims-based analysis looking at clinical outcomes of home INR testing (patient self-testing or PST). The study showed lower rates of adverse events including deep venous thrombosis, pulmonary embolism, bleeding, and stroke as well as fewer emergency department visits among self-testing patients versus those who had office/lab-based monitoring.

Please register to attend the session here: https://fs10.formsite.com/spltrak/miheypirhv/index
Note: Registration is not required to attend, but is highly recommended. Priority to attend will be given to those that pre-register for the session.






Sunday, April 2, 2023


7:45 - 8:15 AMSalon 7
Continental Breakfast

8:15 - 10:25 AMSalon 8
Red Light, Green Light: Starting & Stopping Anticoagulation

Chair(s): Allison Burnett
8:15
Understanding Doac Reversal
Deborah Siegal
University of Ottawa/Ottawa Hospital Research Institute

8:43
Effective Utilization Of Periprocedural Anticoagulation
Bishoy Ragheb
VA Eastern Colorado Health Care System

9:09
Speciality Perspective: Neurosurgeon
Matthew Lawson
Tallahassee Neurological Clinic / Tallahassee Memorial Healthcare / FSU

9:37
Speciality Perspective: Gastroenterologist
Jacob Kurlander
University of Michigan

10:04
Post-Case

10:04
Q&A

10:24
Pre-Case (The Heart Of It All)

10:25 - 10:45 AMSalon 7
Break

10:45 - 12:30 PMSalon 8
The Heart of it All

Chair(s): Bill Dager
10:45
Laao Devices Overview: What, When, Who, And How
Lisa Baumann Kreuziger
Versiti

11:06
Tracking The Heart: Af Detection, Loop Recorders, & Event Monitors
Cara Pellegrini
San Francisco VA / UCSF

11:32
An Overview Of Lv Thrombus
Geoffrey Barnes
University of Michigan

11:56
Post-Case

11:56
Q&A

11:56
Pre-Case (Diagnostic & Prognostic Dilemmas)

12:45 - 1:45 PMSalon 1-4
Anticoagulation Reversal: Real-World Data Matters, Too (Sponsored by AstraZeneca Pharmaceuticals)

Introduction and assessment of real-world data (RWD) is critically important for FXa inhibitor-related bleeds in treatment-emergent situations, particularly since this crucial information has been limited to date within a complex clinical landscape. Join experts to explore how reversal agents can manage life-threatening bleeds in the presence of anticoagulation and learn how the latest published RWD guide reversal and repletion strategies in anticoagulated patients.

In support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and TotalCME, Inc. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Please register to attend the session here: https://www.mededonthego.com/ACRWD
Note: Registration is not required to attend, but is highly recommended. Priority to attend will be given to those that pre-register for the session.




2:00 - 4:05 PMSalon 8
Diagnostic & Prognostic Dilemmas

Chair(s): Scott Kaatz
2:00
D-Dimer, Doac Levels And Other Laboratory Dilemmas
Rita Selby
Associate Professor, Laboratory Medicine and Medicine, University of Toronto

2:35
Diagnosing And Prognostic Models For Vte
Adam Cuker
University of Pennsylvania

2:49
Thrombophilia Testing And Management
Stephan Moll
University of North Carolina School of Medicine

3:16
Addressing Anticoagulation Failure
Anita Rajasekhar
University of Florida

3:43
Post Case

3:45
Q&A

4:05 - 4:25 PMSalon 7
Break

4:25 - 5:45 PMSalon 8
Asked & Answered Rapid Fire

Topics:
  • DOACs in obesity/bariatric surgery
  • DOACs in patients with bioprosthetic valves
  • DOACs in ESRD/Dialysis
  • DOACs in patients with liver disease
  • DOACS for secondary VTE prophylaxis to reduce or not to reduce the dose



Chair(s): Arthur Allen
4:25
Panelists
Mark Crowther, Andrea Van Beek, Scott Kaatz, Anita Rajasekhar, Stephan Moll, Allison Burnett



Monday, April 3, 2023


8:15 - 9:00 AMSalon 1-4
Meet the Expert Breakfast

8:45 - 9:15 AMSalon 7
Continental Breakfast

9:15 - 11:15 AMSalon 8
Crazy Clotting

Chair(s): Mark Crowther
9:15
Location, Location, Location
Scott Woller
Intermountain Medical Center

9:36
Antiphospholipid Syndrome
David Garcia
University of Washington

9:58
Hit & Vitt
Menaka Pai
McMaster University

10:19
Arterial Thrombosis
Jori May
University of Alabama at Birmingham

10:38
Pediatric Clotting
Suzan Williams
Hospital for Sick Children

10:58
Q&A

11:15 - 12:15 PMSalon 8
President's Panel - Difficult Cases

Chair(s): Geoffrey Barnes
11:15
Panelist
Mark Crowther

11:15
Panelist
David Garcia
Univ of Washington

11:15
Panelist
Scott Kaatz
Henry Ford Health

11:15
Panelists
Allison Burnett, Mark Crowther, David Garcia, Scott Kaatz

12:15 - 12:30 PMSalon 8
Wrap Up & Closing